Pub Date : 2025-12-30DOI: 10.1016/j.anplas.2025.11.001
V Mitz
Lip augmentation is a procedure frequently performed by cosmetic physicians, as well as cosmetic and reconstructive surgeons. Atrophy of the lips and the surrounding areas or even in the perioral region is often the result of malformations related to insufficient development of structures during embryogenesis, but also the consequence of tissue aging, which affects patients unequally. The general principle of lip and midfacial augmentation involves injections using needles or cannulas that directly puncture the skin at certain strategic points, in order to correctly position the substance intended to increase tissue thickness. One of the adverse consequences of this approach is sometimes excessive augmentation, which occurs even unintentionally, as it is difficult to precisely control the amount to be injected, even with extensive experience. This is why an alternative approach, which is not new, consists of performing these injections, in certain indications, not transcutaneously but rather intraorally. This approach has already been used for around thirty years by a number of surgeons, notably by a French school of aesthetic surgery and medicine. The depth of the injection is therefore of some interest because it allows for less transformation of the face, since the product will be deposited in contact with the periosteum or soft tissues but relatively far from the skin or labial mucosa. In this technical note, the principles of this deep intraoral injection are detailed, and results are presented as well as rare complications.
{"title":"[Intraoral lip augmentation].","authors":"V Mitz","doi":"10.1016/j.anplas.2025.11.001","DOIUrl":"https://doi.org/10.1016/j.anplas.2025.11.001","url":null,"abstract":"<p><p>Lip augmentation is a procedure frequently performed by cosmetic physicians, as well as cosmetic and reconstructive surgeons. Atrophy of the lips and the surrounding areas or even in the perioral region is often the result of malformations related to insufficient development of structures during embryogenesis, but also the consequence of tissue aging, which affects patients unequally. The general principle of lip and midfacial augmentation involves injections using needles or cannulas that directly puncture the skin at certain strategic points, in order to correctly position the substance intended to increase tissue thickness. One of the adverse consequences of this approach is sometimes excessive augmentation, which occurs even unintentionally, as it is difficult to precisely control the amount to be injected, even with extensive experience. This is why an alternative approach, which is not new, consists of performing these injections, in certain indications, not transcutaneously but rather intraorally. This approach has already been used for around thirty years by a number of surgeons, notably by a French school of aesthetic surgery and medicine. The depth of the injection is therefore of some interest because it allows for less transformation of the face, since the product will be deposited in contact with the periosteum or soft tissues but relatively far from the skin or labial mucosa. In this technical note, the principles of this deep intraoral injection are detailed, and results are presented as well as rare complications.</p>","PeriodicalId":55512,"journal":{"name":"Annales De Chirurgie Plastique Esthetique","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145879494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-29DOI: 10.1016/j.anplas.2025.11.002
V Vaz, A Anantharaju, V G Doddawad
Background: Evidence suggests that altering the surface roughness significantly improves implant osseointegration. Enhancing the hydrophilicity of the implants is a similar strategy as hydrophilic surfaces encourage early osseointegration at 14 and 21 days and hasten the bone-healing process after implant placement. Hence, we evaluate and compare the marginal bone level of hydrophilic and non-hydrophilic implants in mandibular implant overdenture.
Methods and material: The study was a non-randomized, prospective split-mouth design with ten patients, each receiving a hydrophilic implant (Group A) and a non-hydrophilic implant (Group B) on opposite sides of the mandibular arch. An implant-supported overdenture was fitted and monitored at baseline, one month, three months, and six months. Marginal bone loss for the early-loaded hydrophilic implant and conventionally loaded non-hydrophilic implant was measured on each side of the mandibular ridge using an XCP holder and RVG radiographs at each interval. Data was obtained and subjected to statistical analysis using the Wilcoxon signed-rank test and Mann-Whitney U test.
Results: Although there was no statistically significant difference in marginal bone loss between the two implants, the hydrophilic implant achieved similar success with a faster healing time compared to the non-hydrophilic implant.
Conclusions: Hydrophilic implants offer a faster-healing alternative to conventional implants for mandibular overdentures.
{"title":"Non-randomized clinical trial in aesthetic dentistry to evaluate marginal bone level in hydrophilic vs. non-hydrophilic implants for mandibular implant overdentures: A split-mouth design.","authors":"V Vaz, A Anantharaju, V G Doddawad","doi":"10.1016/j.anplas.2025.11.002","DOIUrl":"https://doi.org/10.1016/j.anplas.2025.11.002","url":null,"abstract":"<p><strong>Background: </strong>Evidence suggests that altering the surface roughness significantly improves implant osseointegration. Enhancing the hydrophilicity of the implants is a similar strategy as hydrophilic surfaces encourage early osseointegration at 14 and 21 days and hasten the bone-healing process after implant placement. Hence, we evaluate and compare the marginal bone level of hydrophilic and non-hydrophilic implants in mandibular implant overdenture.</p><p><strong>Methods and material: </strong>The study was a non-randomized, prospective split-mouth design with ten patients, each receiving a hydrophilic implant (Group A) and a non-hydrophilic implant (Group B) on opposite sides of the mandibular arch. An implant-supported overdenture was fitted and monitored at baseline, one month, three months, and six months. Marginal bone loss for the early-loaded hydrophilic implant and conventionally loaded non-hydrophilic implant was measured on each side of the mandibular ridge using an XCP holder and RVG radiographs at each interval. Data was obtained and subjected to statistical analysis using the Wilcoxon signed-rank test and Mann-Whitney U test.</p><p><strong>Results: </strong>Although there was no statistically significant difference in marginal bone loss between the two implants, the hydrophilic implant achieved similar success with a faster healing time compared to the non-hydrophilic implant.</p><p><strong>Conclusions: </strong>Hydrophilic implants offer a faster-healing alternative to conventional implants for mandibular overdentures.</p>","PeriodicalId":55512,"journal":{"name":"Annales De Chirurgie Plastique Esthetique","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145866611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-13DOI: 10.1016/j.anplas.2025.06.015
T Daoulas, P Liverneaux, N Bigorre
Introduction: Microsurgery is becoming increasingly important in many surgical specialities. In France, it is taught as part of university certificates (UC), which are organised in different ways. A previous study carried out in 2014 highlighted several challenges, particularly in terms of finance and structure. This study aims to update this data ten years later to analyse the evolution of microsurgery teaching in France and identify future challenges related to new practices and constraints.
Methods: A descriptive observational survey was performed between January and March 2025 at 28 French university hospitals. The educational referents of the microsurgery university certificates were interviewed using a standardised questionnaire covering teaching methods, hours, assessment methods, registration costs and difficulties encountered. The data collected was compared with that of the 2014 study.
Results: Seventeen centres offered a university certificate in microsurgery, including 14 that already existed in 2014. The average number of hours per year decreased by 24%, while the total number of places offered increased by 86%. Assessment methods remained heterogeneous. The average cost of enrolment in initial training increased by 292 euros. The main challenges identified concerned access to animal models, economic constraints and lack of supervision.
Conclusions: Despite a growing interest in microsurgery training, major disparities persist between university certificates. Standardising programmes, optimising resources and introducing a progressive training pathway could help harmonise practices, while addressing current ethical and logistical issues. We therefore suggest a three-stage model (inert materials, living models, advanced training) to structure learning.
{"title":"State of microsurgery teaching in France in 2025.","authors":"T Daoulas, P Liverneaux, N Bigorre","doi":"10.1016/j.anplas.2025.06.015","DOIUrl":"https://doi.org/10.1016/j.anplas.2025.06.015","url":null,"abstract":"<p><strong>Introduction: </strong>Microsurgery is becoming increasingly important in many surgical specialities. In France, it is taught as part of university certificates (UC), which are organised in different ways. A previous study carried out in 2014 highlighted several challenges, particularly in terms of finance and structure. This study aims to update this data ten years later to analyse the evolution of microsurgery teaching in France and identify future challenges related to new practices and constraints.</p><p><strong>Methods: </strong>A descriptive observational survey was performed between January and March 2025 at 28 French university hospitals. The educational referents of the microsurgery university certificates were interviewed using a standardised questionnaire covering teaching methods, hours, assessment methods, registration costs and difficulties encountered. The data collected was compared with that of the 2014 study.</p><p><strong>Results: </strong>Seventeen centres offered a university certificate in microsurgery, including 14 that already existed in 2014. The average number of hours per year decreased by 24%, while the total number of places offered increased by 86%. Assessment methods remained heterogeneous. The average cost of enrolment in initial training increased by 292 euros. The main challenges identified concerned access to animal models, economic constraints and lack of supervision.</p><p><strong>Conclusions: </strong>Despite a growing interest in microsurgery training, major disparities persist between university certificates. Standardising programmes, optimising resources and introducing a progressive training pathway could help harmonise practices, while addressing current ethical and logistical issues. We therefore suggest a three-stage model (inert materials, living models, advanced training) to structure learning.</p>","PeriodicalId":55512,"journal":{"name":"Annales De Chirurgie Plastique Esthetique","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2025-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145758495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-24DOI: 10.1016/j.anplas.2025.10.003
V Commenge, C Berthier, D Gangloff, T Meresse, J Fraisse
To reconstruct a lower eyelid defect involving two aesthetic cutaneous subunits, we propose the use of bilateral upper eyelid dermatochalasis. A homolateral heteropalpebral flap combined with a contralateral upper eyelid skin graft is our first-line option for cutaneous coverage. In the case of full-thickness defects, a composite tarsoconjunctival graft harvested from the three healthy eyelids provides satisfactory and functionally competent tissue reconstruction.
{"title":"[Two-subunit lower eyelid reconstruction in oncology].","authors":"V Commenge, C Berthier, D Gangloff, T Meresse, J Fraisse","doi":"10.1016/j.anplas.2025.10.003","DOIUrl":"https://doi.org/10.1016/j.anplas.2025.10.003","url":null,"abstract":"<p><p>To reconstruct a lower eyelid defect involving two aesthetic cutaneous subunits, we propose the use of bilateral upper eyelid dermatochalasis. A homolateral heteropalpebral flap combined with a contralateral upper eyelid skin graft is our first-line option for cutaneous coverage. In the case of full-thickness defects, a composite tarsoconjunctival graft harvested from the three healthy eyelids provides satisfactory and functionally competent tissue reconstruction.</p>","PeriodicalId":55512,"journal":{"name":"Annales De Chirurgie Plastique Esthetique","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145607570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-12DOI: 10.1016/j.anplas.2025.10.004
Pierre Maincourt, Thomas Daoulas, Jimmy Pecheur, Anne-Sophie Henry, Yoann David, Marc-Pierre Henry
Introduction: Ballistic injuries to the knee present a complex reconstructive challenge due to associated bone, tendon, and soft tissue loss. Early coordinated management between orthopedic and plastic surgery teams is essential to optimize functional outcomes.
Case report: We report the case of a 22-year-old male who sustained a Gustilo IIIb open fracture of the proximal tibia following a gunshot wound, with avulsion of the tibial tuberosity and complete patellar tendon rupture. Initial debridement and negative pressure therapy were followed, 48hours later, by anatomical reconstruction of the extensor apparatus using an iliac cortico-cancellous graft in continuity with a gluteal fascia strip, reinforced with pedicled semitendinosus and synthetic tape. Skin coverage was achieved with a pedicled lateral genicular artery perforator (LGAP) flap. Rehabilitation included immobilization in extension and progressive physiotherapy-assisted knee flexion.
Discussion: At 18months, the patient presented complete wound healing, no pain at rest, and partial recovery of function (extension deficit 10°, flexion limited to 80°). The Knee injury and Osteoarthritis Outcome Score (KOOS) was 47. Early pedicled perforator flap coverage provided reliable soft tissue reconstruction while avoiding the complexity of microsurgical free flaps in this anatomically challenging region. The composite reconstruction restored mechanical continuity of the extensor apparatus, enabling stable joint function.
Conclusion: This case illustrates the feasibility and functional benefit of early, coordinated orthopedic-plastic reconstruction for complex ballistic knee injuries, combining bone-tendon reconstruction with local perforator flap coverage. Pedicled perforator flaps are a valuable option for small to medium-sized skin defects in the knee region.
{"title":"Anatomical reconstruction of the patellar tendon with coverage using a perforator LGAP flap in ballistic trauma: The importance of interdisciplinary collaboration.","authors":"Pierre Maincourt, Thomas Daoulas, Jimmy Pecheur, Anne-Sophie Henry, Yoann David, Marc-Pierre Henry","doi":"10.1016/j.anplas.2025.10.004","DOIUrl":"https://doi.org/10.1016/j.anplas.2025.10.004","url":null,"abstract":"<p><strong>Introduction: </strong>Ballistic injuries to the knee present a complex reconstructive challenge due to associated bone, tendon, and soft tissue loss. Early coordinated management between orthopedic and plastic surgery teams is essential to optimize functional outcomes.</p><p><strong>Case report: </strong>We report the case of a 22-year-old male who sustained a Gustilo IIIb open fracture of the proximal tibia following a gunshot wound, with avulsion of the tibial tuberosity and complete patellar tendon rupture. Initial debridement and negative pressure therapy were followed, 48hours later, by anatomical reconstruction of the extensor apparatus using an iliac cortico-cancellous graft in continuity with a gluteal fascia strip, reinforced with pedicled semitendinosus and synthetic tape. Skin coverage was achieved with a pedicled lateral genicular artery perforator (LGAP) flap. Rehabilitation included immobilization in extension and progressive physiotherapy-assisted knee flexion.</p><p><strong>Discussion: </strong>At 18months, the patient presented complete wound healing, no pain at rest, and partial recovery of function (extension deficit 10°, flexion limited to 80°). The Knee injury and Osteoarthritis Outcome Score (KOOS) was 47. Early pedicled perforator flap coverage provided reliable soft tissue reconstruction while avoiding the complexity of microsurgical free flaps in this anatomically challenging region. The composite reconstruction restored mechanical continuity of the extensor apparatus, enabling stable joint function.</p><p><strong>Conclusion: </strong>This case illustrates the feasibility and functional benefit of early, coordinated orthopedic-plastic reconstruction for complex ballistic knee injuries, combining bone-tendon reconstruction with local perforator flap coverage. Pedicled perforator flaps are a valuable option for small to medium-sized skin defects in the knee region.</p>","PeriodicalId":55512,"journal":{"name":"Annales De Chirurgie Plastique Esthetique","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2025-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145514824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1016/j.anplas.2025.05.001
D. Stoppa-Lyonnet , C. Colas
Depuis 30 ans après l’identification des gènes BRCA1 et BRCA2, le panorama des tests de prédisposition aux cancers du sein n’a cessé de se préciser : aujourd’hui le séquençage très haut débit permet l’étude de huit gènes de prédisposition, les indications ne cessent de s’élargir avec comme nouvelle porte d’entrée l’identification d’altérations BRCA1/2 au niveau tumoral dont l’origine est constitutionnelle dans 75 % des cas. Si les tests permettent en cas de facteur de risque identifié une prise en charge adaptée de prévention, de nombreux défis restent à relever : identification de nouveaux gènes de prédisposition ou plutôt validation de gènes candidat dont ATM, détection de nouveaux modes d’inactivation des gènes déjà inscrits dans le diagnostic (délétions à distance, modifications épigénétiques), classification en pathogène ou bénin des variants de signification inconnue, identification et prise en compte dans des modèles multifactoriels de risque des facteurs modificateurs, génétiques ou non. Les patients, leurs apparentés ont joué et continuent de jouer un rôle majeur dans le développement de l’oncogénétique. Nous leur devons des tests de qualité, information, accompagnement et protection.
Over the past 30 years, since the identification of the BRCA1 and BRCA2 genes, the panorama of breast cancer predisposition tests has continued to evolve: today, ultra-high-throughput sequencing enables the study of eight predisposition genes, and indications are constantly expanding, with the new entry point being the identification of BRCA1/2 alterations in tumors, 75% of which are of constitutional origin. While these tests can be used to provide appropriate preventive treatment in cases where risk factors have been identified, many challenges remain to be met: identification of new predisposition genes, or rather validation of candidate genes such as ATM, detection of new modes of inactivation of genes already included in the diagnosis (remote deletions, epigenetic modifications), classification of variants of unknown significance as pathogenic or benign, and identification and inclusion of modifying factors, whether genetic or not, in multifactorial risk models. Patients and their relatives have played, and continue to play, a major role in the development of oncogenetics. We owe them quality tests, information, support and protection.
30年来的BRCA1和BRCA2基因鉴定后,对乳腺癌易感性检测全景一再澄清:自己现在允许研究、高通量测序八个易感基因,不断扩大同作为新标志、前门识别机能宪制层面BRCA1/2原点位于肿瘤中有75%的病例。虽然检测可以在确定的风险因素的情况下提供适当的预防管理,但仍有许多挑战有待克服:确定新易感基因,或者说验证候选人其中ATM基因检测、基因的失活的新模式已经列入(缺失的远程诊断、分类性变异),在贝宁或致病变异的含义不明,多因素模型的识别并体现在是否调节剂、遗传因素的风险。患者及其亲属在肿瘤遗传学的发展中发挥了并将继续发挥重要作用。我们欠他们质量测试、信息、支持和保护。Over the past 30 years since the, the识别BRCA1和BRCA2基因检测乳腺癌predisposition过客has to the概况》的资源:today, ultra-high-throughput sequencing enables the study of游廊predisposition基因里,and are标志可以不断扩大的自在,with the new entry point in tumors BRCA1/2改变的鉴定》,宪法中75% of which are of origin。虽然这些检测可用于在已确定危险因素的情况下提供适当的预防性治疗,但仍需克服许多挑战:of new predisposition基因”的标识,向我验证候选基因,such as ATM detection of new时尚基因失活,学会那里的in the用电(epigenetic remote缺失在内的改动),指定的变异都学会分类,as pathogenic 8金、善意和鉴定与包容of modifying理,如果遗传or not,冠心病risk models。患者及其亲属在肿瘤遗传学的发展中发挥了并将继续发挥重要作用。我们有质量测试,信息,支持和保护。
{"title":"Prédispositions génétiques aux cancers du sein","authors":"D. Stoppa-Lyonnet , C. Colas","doi":"10.1016/j.anplas.2025.05.001","DOIUrl":"10.1016/j.anplas.2025.05.001","url":null,"abstract":"<div><div>Depuis 30 ans après l’identification des gènes <em>BRCA1</em> et <em>BRCA2</em>, le panorama des tests de prédisposition aux cancers du sein n’a cessé de se préciser : aujourd’hui le séquençage très haut débit permet l’étude de huit gènes de prédisposition, les indications ne cessent de s’élargir avec comme nouvelle porte d’entrée l’identification d’altérations <em>BRCA1/2</em> au niveau tumoral dont l’origine est constitutionnelle dans 75 % des cas. Si les tests permettent en cas de facteur de risque identifié une prise en charge adaptée de prévention, de nombreux défis restent à relever : identification de nouveaux gènes de prédisposition ou plutôt validation de gènes candidat dont <em>ATM</em>, détection de nouveaux modes d’inactivation des gènes déjà inscrits dans le diagnostic (délétions à distance, modifications épigénétiques), classification en pathogène ou bénin des variants de signification inconnue, identification et prise en compte dans des modèles multifactoriels de risque des facteurs modificateurs, génétiques ou non. Les patients, leurs apparentés ont joué et continuent de jouer un rôle majeur dans le développement de l’oncogénétique. Nous leur devons des tests de qualité, information, accompagnement et protection.</div></div><div><div>Over the past 30 years, since the identification of the <em>BRCA1</em> and <em>BRCA2</em> genes, the panorama of breast cancer predisposition tests has continued to evolve: today, ultra-high-throughput sequencing enables the study of eight predisposition genes, and indications are constantly expanding, with the new entry point being the identification of <em>BRCA1/2</em> alterations in tumors, 75% of which are of constitutional origin. While these tests can be used to provide appropriate preventive treatment in cases where risk factors have been identified, many challenges remain to be met: identification of new predisposition genes, or rather validation of candidate genes such as <em>ATM</em>, detection of new modes of inactivation of genes already included in the diagnosis (remote deletions, epigenetic modifications), classification of variants of unknown significance as pathogenic or benign, and identification and inclusion of modifying factors, whether genetic or not, in multifactorial risk models. Patients and their relatives have played, and continue to play, a major role in the development of oncogenetics. We owe them quality tests, information, support and protection.</div></div>","PeriodicalId":55512,"journal":{"name":"Annales De Chirurgie Plastique Esthetique","volume":"70 6","pages":"Pages 609-614"},"PeriodicalIF":0.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145486285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1016/j.anplas.2025.05.008
S. Bonvalot, J.-P. Binder, L. Darrigues, V. Pineau, B. Couturaud
Une masse superficielle ou profonde au niveau des membres et parois est susceptible d’être un sarcome même si elle préexistait de longue date. Elle incite à la prudence car une chirurgie inadaptée péjore le pronostic. Une tumeur superficielle relève d’une échographie : si la tumeur n’est pas parfaitement graisseuse et homogène, une biopsie percutanée est nécessaire. Les tumeurs profondes doivent avoir une IRM suivie d’une biopsie percutanée. Il faut attendre le résultat anatomopathologique définitif qui peut faire appel à de la biologie moléculaire en complément de l’immunohistochimie. S’il s’agit d’un sarcome ou d’une tumeur desmoïde, la stratégie thérapeutique doit être décidée en réunion de concertation pluridisciplinaire spécialisée. Les sarcomes relèvent d’une exérèse large en passant à distance de la lésion afin d’obtenir des marges saines. En France, il existe un réseau de centres spécialisés dans le traitement des sarcomes (NETSARC+).
A superficial or deep mass in the limbs or body walls may be a sarcoma, even if it has been present for a long time. It warrants caution, as inappropriate surgery can worsen the prognosis. A superficial tumor should be evaluated with an ultrasound: if the tumor is not perfectly fatty and homogeneous, a percutaneous biopsy is necessary. Deep tumors require an MRI followed by a percutaneous biopsy. The final histopathological diagnosis must be awaited, which may include molecular biology in addition to immunohistochemistry. If it is a sarcoma or a desmoid tumor, the therapeutic strategy must be decided in a specialized multidisciplinary team meeting. Sarcomas require wide excision, ensuring healthy margins by staying well away from the lesion. In France, there is a network of specialized centers for the treatment of sarcomas (NETSARC+).
{"title":"Stratégie thérapeutique des tumeurs des tissus mous et sarcomes périphériques de l’adulte","authors":"S. Bonvalot, J.-P. Binder, L. Darrigues, V. Pineau, B. Couturaud","doi":"10.1016/j.anplas.2025.05.008","DOIUrl":"10.1016/j.anplas.2025.05.008","url":null,"abstract":"<div><div>Une masse superficielle ou profonde au niveau des membres et parois est susceptible d’être un sarcome même si elle préexistait de longue date. Elle incite à la prudence car une chirurgie inadaptée péjore le pronostic. Une tumeur superficielle relève d’une échographie : si la tumeur n’est pas parfaitement graisseuse et homogène, une biopsie percutanée est nécessaire. Les tumeurs profondes doivent avoir une IRM suivie d’une biopsie percutanée. Il faut attendre le résultat anatomopathologique définitif qui peut faire appel à de la biologie moléculaire en complément de l’immunohistochimie. S’il s’agit d’un sarcome ou d’une tumeur desmoïde, la stratégie thérapeutique doit être décidée en réunion de concertation pluridisciplinaire spécialisée. Les sarcomes relèvent d’une exérèse large en passant à distance de la lésion afin d’obtenir des marges saines. En France, il existe un réseau de centres spécialisés dans le traitement des sarcomes (NETSARC<sup>+</sup>).</div></div><div><div>A superficial or deep mass in the limbs or body walls may be a sarcoma, even if it has been present for a long time. It warrants caution, as inappropriate surgery can worsen the prognosis. A superficial tumor should be evaluated with an ultrasound: if the tumor is not perfectly fatty and homogeneous, a percutaneous biopsy is necessary. Deep tumors require an MRI followed by a percutaneous biopsy. The final histopathological diagnosis must be awaited, which may include molecular biology in addition to immunohistochemistry. If it is a sarcoma or a desmoid tumor, the therapeutic strategy must be decided in a specialized multidisciplinary team meeting. Sarcomas require wide excision, ensuring healthy margins by staying well away from the lesion. In France, there is a network of specialized centers for the treatment of sarcomas (NETSARC<sup>+</sup>).</div></div>","PeriodicalId":55512,"journal":{"name":"Annales De Chirurgie Plastique Esthetique","volume":"70 6","pages":"Pages 590-597"},"PeriodicalIF":0.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145486191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1016/j.anplas.2025.06.004
M. Goutard, A. Glorion, N. Leymarie
<div><div>Le chirurgien plasticien tient une place centrale dans la prise en charge du cancer du sein, de la prévention au suivi post-thérapeutique. La chirurgie esthétique du sein représente une part importante de l’activité de chirurgie plastique en France. Cette pratique place les plasticiens en position privilégiée pour le dépistage précoce du cancer du sein, leur permettant d’identifier les patientes à haut risque et de les orienter vers une surveillance personnalisée. Lors des réunions de concertation pluridisciplinaire, l’expertise du plasticien oriente la stratégie thérapeutique. En évaluant l’impact esthétique et fonctionnel des traitements, il définit avec le chirurgien oncologue une approche chirurgicale qui respecte les impératifs oncologiques tout en limitant les séquelles esthétiques et fonctionnelles. Les techniques d’oncoplastie mammaire se sont imposées dans le traitement conservateur du sein, associant exérèse tumorale et remodelage glandulaire. La reconstruction mammaire fait partie intégrante du traitement et doit être systématiquement proposée en cas de mastectomie. La reconstruction immédiate est discutée selon les caractéristiques histologiques du cancer et les traitements adjuvants prévus. Lors du suivi post-thérapeutique, le chirurgien plasticien finalise la reconstruction mammaire et prend en charge les séquelles des traitements conservateurs par lipofilling ou gestes de symétrisation. Cette prise en charge globale fait du chirurgien plasticien un acteur incontournable de la cancérologie mammaire moderne.</div></div><div><div>Plastic surgeons play a central role in the management of breast cancer, from prevention to post-treatment follow-up. Aesthetic breast surgery accounts for a significant proportion of plastic surgery in France. This practice places plastic surgeons in a privileged position for the early detection of breast cancer, enabling them to identify high-risk patients and steer them towards personalized monitoring. During multidisciplinary consultation meetings, the plastic surgeon's expertise guides the therapeutic strategy. By assessing the aesthetic and functional impact of treatments, he works with the surgical oncologist to define a surgical approach that respects oncological imperatives while limiting aesthetic and functional after-effects. Breast oncoplastic techniques have become an established part of conservative breast treatment, combining tumour removal and glandular remodelling. Breast reconstruction is an integral part of treatment, and must be systematically proposed in the event of mastectomy. Immediate reconstruction is discussed according to the histological characteristics of the cancer and the adjuvant treatments planned. During post-treatment follow-up, the plastic surgeon finalizes the breast reconstruction and manages the after-effects of conservative treatments through lipofilling or symmetrization procedures. This comprehensive approach makes the plastic surgeon a key player in modern
{"title":"Le rôle du chirurgien plasticien dans la prise en charge du cancer du sein","authors":"M. Goutard, A. Glorion, N. Leymarie","doi":"10.1016/j.anplas.2025.06.004","DOIUrl":"10.1016/j.anplas.2025.06.004","url":null,"abstract":"<div><div>Le chirurgien plasticien tient une place centrale dans la prise en charge du cancer du sein, de la prévention au suivi post-thérapeutique. La chirurgie esthétique du sein représente une part importante de l’activité de chirurgie plastique en France. Cette pratique place les plasticiens en position privilégiée pour le dépistage précoce du cancer du sein, leur permettant d’identifier les patientes à haut risque et de les orienter vers une surveillance personnalisée. Lors des réunions de concertation pluridisciplinaire, l’expertise du plasticien oriente la stratégie thérapeutique. En évaluant l’impact esthétique et fonctionnel des traitements, il définit avec le chirurgien oncologue une approche chirurgicale qui respecte les impératifs oncologiques tout en limitant les séquelles esthétiques et fonctionnelles. Les techniques d’oncoplastie mammaire se sont imposées dans le traitement conservateur du sein, associant exérèse tumorale et remodelage glandulaire. La reconstruction mammaire fait partie intégrante du traitement et doit être systématiquement proposée en cas de mastectomie. La reconstruction immédiate est discutée selon les caractéristiques histologiques du cancer et les traitements adjuvants prévus. Lors du suivi post-thérapeutique, le chirurgien plasticien finalise la reconstruction mammaire et prend en charge les séquelles des traitements conservateurs par lipofilling ou gestes de symétrisation. Cette prise en charge globale fait du chirurgien plasticien un acteur incontournable de la cancérologie mammaire moderne.</div></div><div><div>Plastic surgeons play a central role in the management of breast cancer, from prevention to post-treatment follow-up. Aesthetic breast surgery accounts for a significant proportion of plastic surgery in France. This practice places plastic surgeons in a privileged position for the early detection of breast cancer, enabling them to identify high-risk patients and steer them towards personalized monitoring. During multidisciplinary consultation meetings, the plastic surgeon's expertise guides the therapeutic strategy. By assessing the aesthetic and functional impact of treatments, he works with the surgical oncologist to define a surgical approach that respects oncological imperatives while limiting aesthetic and functional after-effects. Breast oncoplastic techniques have become an established part of conservative breast treatment, combining tumour removal and glandular remodelling. Breast reconstruction is an integral part of treatment, and must be systematically proposed in the event of mastectomy. Immediate reconstruction is discussed according to the histological characteristics of the cancer and the adjuvant treatments planned. During post-treatment follow-up, the plastic surgeon finalizes the breast reconstruction and manages the after-effects of conservative treatments through lipofilling or symmetrization procedures. This comprehensive approach makes the plastic surgeon a key player in modern","PeriodicalId":55512,"journal":{"name":"Annales De Chirurgie Plastique Esthetique","volume":"70 6","pages":"Pages 522-527"},"PeriodicalIF":0.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145486205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1016/j.anplas.2025.05.019
R. Bosc
En l’absence de données probantes concernant le diagnostic et la prise en charge du LAGC-AIM causé par les implants mammaires texturés, cet article vise à fournir des recommandations fondées, d’une part sur les données actualisées de la littérature, d’autre part sur l’expérience acquise dans la prise en charge et le traitement des patientes au sein du groupe français d’étude sur le LAGC-AIM. Une recherche a été menée dans les bases de données MEDLINE et Cochrane complétée par des recherches manuelles d’articles pertinents en anglais. Les études portant sur la chirurgie mammaire et le lymphome associé aux implants mammaires ont été incluses. Les articles les plus probants ont été intégrés pour synthétiser les recommandations et déterminer l’incidence, la présentation clinique, les facteurs de risque, les différentes thérapeutiques et la surveillance. Les chirurgiens poseurs de prothèses mammaires doivent prendre conscience des risques spécifiques liés à ces dispositifs médicaux. Les risques à court terme doivent être considérés de manière aussi attentive que les risques à long terme. Les modifications d’un dispositif médical, aussi infimes soient-elles, peuvent engendrer des risques accrus inattendus. Au-delà des procédures habituelles de sécurisation et d’agrément lors de l’introduction sur le marché d’un dispositif médical, la mise en place d’une surveillance appropriée des patientes et les déclarations des évènements indésirables constituent le préalable indispensable à la mise en œuvre des enquêtes d’imputabilité et des éventuelles mesures correctives.
In the absence of evidence regarding the diagnosis and management of LAGC-AIM caused by textured breast implants, this article aims to provide recommendations based, on the one hand, on updated data from the literature, and on the other hand, on the experience gained in the management and treatment of patients within the French LAGC-AIM study group. A search was carried out in the MEDLINE and Cochrane databases, supplemented by manual searches for relevant articles in English. Studies on breast surgery and breast implant-associated lymphoma were included. The most convincing articles were integrated to synthesize recommendations and determine incidence, clinical presentation, risk factors, different therapies and surveillance. Breast implant surgeons need to be aware of the specific risks associated with these medical devices. Short-term risks must be considered as carefully as long-term risks. Modifications to a medical device, no matter how small, can lead to unexpected increased risks. In addition to the usual safety and approval procedures for the market launch of a medical device, appropriate patient monitoring and adverse event reporting are essential prerequisites for the implementation of imputability investigations and any corrective measures.
没有证据就诊断并接管LAGC-AIM隆胸所造成的变形,本文旨在提供建议,一方面是基于对文学的最新数据,另一方面是经验的照顾和治疗的病人在集团内LAGC-AIM上学习法语。对MEDLINE和Cochrane数据库进行了搜索,并手动搜索了相关的英文文章。包括乳房手术和与乳房植入物相关的淋巴瘤的研究。最好的证据被纳入综合建议,并确定发病率、临床表现、风险因素、治疗选择和监测。使用乳房假体的外科医生必须意识到与这些医疗设备相关的特定风险。必须像对待长期风险一样对待短期风险。医疗设备的改变,即使是最小的改变,也可能导致意想不到的风险增加。超出安全标准程序和审批时市场上引入医疗器械”,让病人建立适当监测和不良事件的声明的先决条件是实施问责调查和可能的补救措施。In the集的证据缺乏关于谈话中by the用电and management of LAGC-AIM建立新的植入丰胸,这篇aims to provide建议为基础,on the one hand,更新的data from the文学,and on the other hand, the体验ainsi In the management and of within the French LAGC-AIM study group)的患者治疗。在MEDLINE和Cochrane数据库中进行了搜索,并手动搜索了英文相关文章。包括乳房手术和乳房植入相关淋巴瘤的研究。最令人信服的文章被整合到综合建议中,并确定了发病率、临床表现、风险因素、不同的治疗和监测。乳房植入外科医生需要意识到与这些医疗设备相关的具体风险。短期风险必须与长期风险一样谨慎对待。对医疗设备的修改,无论多么小,都可能导致意想不到的风险增加。除了向市场推出医疗设备的通常安全和批准程序外,适当的患者监测和不良事件报告是实施问责调查和任何纠正措施的基本先决条件。
{"title":"Prothèses et cancer : le lymphome anaplasique à grandes cellules","authors":"R. Bosc","doi":"10.1016/j.anplas.2025.05.019","DOIUrl":"10.1016/j.anplas.2025.05.019","url":null,"abstract":"<div><div>En l’absence de données probantes concernant le diagnostic et la prise en charge du LAGC-AIM causé par les implants mammaires texturés, cet article vise à fournir des recommandations fondées, d’une part sur les données actualisées de la littérature, d’autre part sur l’expérience acquise dans la prise en charge et le traitement des patientes au sein du groupe français d’étude sur le LAGC-AIM. Une recherche a été menée dans les bases de données MEDLINE et Cochrane complétée par des recherches manuelles d’articles pertinents en anglais. Les études portant sur la chirurgie mammaire et le lymphome associé aux implants mammaires ont été incluses. Les articles les plus probants ont été intégrés pour synthétiser les recommandations et déterminer l’incidence, la présentation clinique, les facteurs de risque, les différentes thérapeutiques et la surveillance. Les chirurgiens poseurs de prothèses mammaires doivent prendre conscience des risques spécifiques liés à ces dispositifs médicaux. Les risques à court terme doivent être considérés de manière aussi attentive que les risques à long terme. Les modifications d’un dispositif médical, aussi infimes soient-elles, peuvent engendrer des risques accrus inattendus. Au-delà des procédures habituelles de sécurisation et d’agrément lors de l’introduction sur le marché d’un dispositif médical, la mise en place d’une surveillance appropriée des patientes et les déclarations des évènements indésirables constituent le préalable indispensable à la mise en œuvre des enquêtes d’imputabilité et des éventuelles mesures correctives.</div></div><div><div>In the absence of evidence regarding the diagnosis and management of LAGC-AIM caused by textured breast implants, this article aims to provide recommendations based, on the one hand, on updated data from the literature, and on the other hand, on the experience gained in the management and treatment of patients within the French LAGC-AIM study group. A search was carried out in the MEDLINE and Cochrane databases, supplemented by manual searches for relevant articles in English. Studies on breast surgery and breast implant-associated lymphoma were included. The most convincing articles were integrated to synthesize recommendations and determine incidence, clinical presentation, risk factors, different therapies and surveillance. Breast implant surgeons need to be aware of the specific risks associated with these medical devices. Short-term risks must be considered as carefully as long-term risks. Modifications to a medical device, no matter how small, can lead to unexpected increased risks. In addition to the usual safety and approval procedures for the market launch of a medical device, appropriate patient monitoring and adverse event reporting are essential prerequisites for the implementation of imputability investigations and any corrective measures.</div></div>","PeriodicalId":55512,"journal":{"name":"Annales De Chirurgie Plastique Esthetique","volume":"70 6","pages":"Pages 572-580"},"PeriodicalIF":0.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145486213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1016/j.anplas.2025.05.003
C. Lheure
Le mélanome est une tumeur le plus souvent cutanée, développée aux dépens de mélanocytes tumoraux. Son incidence double tous les 10 ans en France. Il existe des facteurs de risque intrinsèques et extrinsèques (exposition UV principalement). En cas de suspicion diagnostique clinique, la prise en charge consistera en une exérèse première sans marge, puis une reprise de marges adaptée à l’indice de Breslow. La réalisation d’un ganglion sentinelle lors de la reprise de marges sera réalisée selon l’indice de Breslow, l’état général et l’âge du patient. Un bilan d’extension sera à réaliser en fonction du stade du mélanome opéré.
Melanoma is a tumor most often found in the skin, developed at the expense of tumor melanocytes. Its incidence doubles every 10 years in France. There are intrinsic and extrinsic risk factors (mainly UV exposure). If a clinical diagnosis is suspected, treatment consists of initial resection without margins, followed by resection of the margins according to the Breslow index. A sentinel lymph node may be included in the revision margin, depending on the Breslow index, the patient's general condition and age. An extension assessment will be carried out depending on the stage of the melanoma operated on.
{"title":"Mélanome (partie 1)","authors":"C. Lheure","doi":"10.1016/j.anplas.2025.05.003","DOIUrl":"10.1016/j.anplas.2025.05.003","url":null,"abstract":"<div><div>Le mélanome est une tumeur le plus souvent cutanée, développée aux dépens de mélanocytes tumoraux. Son incidence double tous les 10 ans en France. Il existe des facteurs de risque intrinsèques et extrinsèques (exposition UV principalement). En cas de suspicion diagnostique clinique, la prise en charge consistera en une exérèse première sans marge, puis une reprise de marges adaptée à l’indice de Breslow. La réalisation d’un ganglion sentinelle lors de la reprise de marges sera réalisée selon l’indice de Breslow, l’état général et l’âge du patient. Un bilan d’extension sera à réaliser en fonction du stade du mélanome opéré.</div></div><div><div>Melanoma is a tumor most often found in the skin, developed at the expense of tumor melanocytes. Its incidence doubles every 10 years in France. There are intrinsic and extrinsic risk factors (mainly UV exposure). If a clinical diagnosis is suspected, treatment consists of initial resection without margins, followed by resection of the margins according to the Breslow index. A sentinel lymph node may be included in the revision margin, depending on the Breslow index, the patient's general condition and age. An extension assessment will be carried out depending on the stage of the melanoma operated on.</div></div>","PeriodicalId":55512,"journal":{"name":"Annales De Chirurgie Plastique Esthetique","volume":"70 6","pages":"Pages 461-465"},"PeriodicalIF":0.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145486099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}